Publication:
Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders

dc.contributor.authorCetin, Ihsan
dc.contributor.authorTezdig, Ihsan
dc.contributor.authorTARAKCIOGLU, Mahmut Cem
dc.contributor.authorKadak, Muhammed Tayyib
dc.contributor.authorDemirel, Omer Faruk
dc.contributor.authorOzer, Omer Faruk
dc.contributor.institutionauthorÖZER, ÖMER FARUK
dc.date.accessioned2020-10-29T14:01:50Z
dc.date.available2020-10-29T14:01:50Z
dc.date.issued2016-01-01T00:00:00Z
dc.description.abstractContext: Improved biomarkers would facilitate the diagnosis and treatment of autism spectrum disorders (ASD).
dc.identifier.citationCetin I., Tezdig I., TARAKCIOGLU M. C. , Kadak M. T. , Demirel O. F. , Ozer O. F. , -Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders-, BIOMARKERS, cilt.21, ss.614-618, 2016
dc.identifier.doi10.3109/1354750x.2016.1171901
dc.identifier.pubmed27097671
dc.identifier.scopus84964433761
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25211
dc.identifier.wosWOS:000385399600006
dc.titleSerum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders
dc.typeArticle
dspace.entity.typePublication
local.avesis.id1871236d-c04a-4d59-b19e-d5b22ddad1d8
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublicationf5267834-a664-4da6-89f3-ae19762e1423
relation.isAuthorOfPublication.latestForDiscoveryf5267834-a664-4da6-89f3-ae19762e1423

Files